Compare stocks

AIRS vs BMGL

vs

AirSculpt Technologies, Inc. Common Stock and Basel Medical Group Ltd Ordinary Shares

Sources and methodology ↗

Compare any two stock symbols.

2 of 3 daily views used · 1 remaining. Refreshes and chart changes do not use another view.

Daily close · 2026-11-05

Price return

Both stocks start at 0% on the first shared trading day.

AIRS-69.23%
BMGL-90.26%
Price return: AIRS and BMGLHistorical recorded observations on the same scale. Missing metrics leave gaps.-114%-43%27%98%168%Feb 25Jun 25Oct 25Mar 26Jul 26Nov 26

Use left and right arrow keys to inspect historical line observations. Financial bars can be focused individually.

Split-adjusted closing prices. Dividends are excluded.Year ranges begin January 1 of the end year minus the selected years.
Aurora
AURORA

Ask about these stocks.

CONTEXT ATTACHEDAIRS + BMGLPrices, financials and SEC filing evidence

Uses research tokens · Agent runs can use more

Similarity
Limited detail
1 shared / 1 total tags

The available classifications are too broad to identify close peers. Compare the business descriptions and filing evidence below.

How similar are their businesses?

The score compares business activities in annual filings released in 2025. Core activities receive four times the weight of material activities. Industries that fewer companies share carry more weight.

Healthcare
How we measure overlap ↗
The businesses behind the score

Industry overlap

Filing-derived business activity overlapCounts of retained positive business classifications. Circle sizes do not encode the counts or the weighted similarity score.AIRS only0Shared1BMGL only0

AIRS only · 0

No activities in this group.

Shared activities · 1

BMGL only · 0

No activities in this group.

Positive activities from the two selected annual filings. Expand each group to view all its activities, or use the complete table below. These are classification sets, not revenue shares. The weighted similarity score also accounts for exposure and how common each activity is.
Show business activity table · 1 row, 3 columns

Core activities receive full weight; material activities receive one quarter. Select a tag to read the filing evidence.

Business activityAIRSBMGL
CoreCore

Healthcare

AIRS Core

Annual filing released 2025-03-14 · GPT 6 Luna

Item 1. Business Unless otherwise indicated or the context otherwise requires, references in this Annual Report on Form 10-K to the “Company,” “AirSculpt,” “we,” “us” and “our” refer to AirSculpt Technologies, Inc. and its consolidated subsidiaries and the Professional Associations (as defined hereinafter). Our Company AirSculpt is a next-generation body contouring treatment designed to optimize both comfort and precision, available exclusively at AirSculpt offices. The minimally invasive procedure removes fat and tightens skin, while sculpting targeted areas of the body, allowing for quick healing with minimal bruising, tighter skin, and precise results. We believe our treatment results and elite patient experience have positioned AirSculpt as a preferred body contouring brand. We performed 14,036 body contouring procedures in 2024.
Components of Results of Operations Revenue Our revenue is generated from our patented AirSculpt® procedures performed on our patients. We are 100% self-pay and do not accept payments from the U.S. federal government or payer organizations. We assist patients, as needed, by providing third-party financing options to pay for procedures. We have arrangements with various financing companies to 55 Table of Contents
Read the annual filing ↗

BMGL Core

Annual filing released 2025-11-18 · GPT 6 Luna

Basel Medical Group Ltd, or “Basel Medical”, is a BVI business company incorporated in the BVI. Basel Medical serves as the holding company of our Group and we conduct our operations through our operating subsidiaries based in Singapore. We provide a wide spectrum of general and subspecialized orthopedic including but not limited to trauma and sports medicine services such as knee/hip replacements, sports medicine/surgery, spine surgery, foot/ankle surgery and minimally invasive orthopedic procedures, as well as neurosurgical treatments. Also, we have health screening services, mental health, woman’s health and general practice services as well.
We currently have 14 medical practitioners in our Group, comprising four specialists and 10 general practitioners. The services provided by our clinics include, but are not limited to, consultation, medical diagnosis and medical or surgical treatments for orthopedic, trauma, sports medicine, general practice, health screening, mental health, women’s health and neurosurgical conditions and our clinics are equipped with the facilities needed to perform a variety of procedures on site and minor surgical services. Major surgeries will be carried out at Gleneagles Hospital, Mount Elizabeth Hospital, Mount Elizabeth Novena Hospital, Parkway East Hospital, Mount Alvernia Hospital, Farrer Park Hospital and other day surgery centers in Singapore where our medical practitioners are accredited to practice.
Read the annual filing ↗
What each company does

Compare the businesses

AirSculpt Technologies, Inc. Common Stock

AIRS · XNAS

AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States, Canada, and the United Kingdom. The company offers AirSculpt, a body contouring treatment that removes fat and tightens skin while sculpting targeted areas of the body in a minimally invasive procedure. It also provides AirSculpt+, a procedure that permanently removes fat and tightens the skin with unparalleled precision and finesse; and AirSculpt Smooth, an advanced cellulite removal tool. In addition, it provides fat removal procedures across treatment areas, such as the stomach, back, and buttocks; and fat transfer procedures that transfers the patient's own fat cells to enhance the buttocks, breasts, hips, aging hands, or other areas. Further, the company's body contouring procedures include the Power BBL, a Brazilian butt lift procedure; the Up a Cup, a breast enhancement procedure; and the Hip Flip, an hourglass contouring procedure. Additionally, it operates various centers. AirSculpt Technologies, Inc. was founded in 2012 and is headquartered in Miami Beach, Florida.

Open AIRS dashboard ↗

Basel Medical Group Ltd Ordinary Shares

BMGL · XNAS

Basel Medical Group Ltd provides healthcare services in Singapore. The company offers general and subspecialized orthopedic, trauma, sports medicine, and neurosurgical services, such as knee/hip replacements, sports medicine/surgery, spine surgery, foot/ankle surgery, and minimally invasive orthopedic procedures, as well as other complex neurosurgical procedures. Its services also include consultation, medical diagnosis, and medical and surgical treatments for orthopedic, trauma, sports medicine, and neurological conditions, as well as physiotherapy services. The company was incorporated in 2023 and is headquartered in Singapore.

Open BMGL dashboard ↗
Financial data

Fundamentals side by side

Explore financial charts ↑
Show fundamentals table · 11 rows, 3 columns
MetricAIRSBMGL
ExchangeXNASXNAS
SectorHealthcareHealthcare
IndustryMedical Care FacilitiesMedical Care Facilities
Market observation2026-11-052026-11-05
Closing price (USD)$1.44$5.19
Market cap (USD)$103.82M$70.49M
P/E (TTM)UnavailableUnavailable
Latest annual period2025-12-312026-06-30
Revenue (annual, USD)$151.82M$12.81M
Net income (annual, USD)$-11.67M$-1.11M
Gross margin (annual)UnavailableUnavailable

USD values from stored observations. Fiscal period endings and availability dates may differ.

AIRS period ended 2025-12-31 · available 2026-04-06 · SEC filing ↗BMGL period ended 2026-06-30 · available 2026-10-30 · SEC filing ↗
Behind the comparison

Sources and methodology

Price return uses split-adjusted daily closes and excludes dividends. Both stocks start on the first shared trading day within the selected window. Unavailable metrics leave gaps.

Financials use SEC canonical statements available by the displayed cutoff, retaining each company's fiscal period end. Annual and quarterly amounts are shown separately. P/E is unavailable when earnings do not support a positive ratio.

Business overlap uses industry tags from annual filings released in 2025. Each core activity receives full weight; each material activity receives one quarter of that weight. Rarer industries carry more weight. We sum the smaller exposure for each shared activity and divide it by the sum of the larger exposure for every activity in either company. This measures business overlap, rather than price correlation or expected returns.

Search eligibility requires distinct issuers, a shared core category and at least 20% weighted overlap, supported by industry or sector evidence and specific business activities. Broad classifications require stronger overlap within the same sector. Comparisons also need at least 252 shared price observations within two years, recent trading and a common sourced revenue or net-income trend. Missing P/E or gross margin alone does not exclude a comparison. The eligibility snapshot refreshes daily. Related comparisons use a separate, stricter peer rule; their ten-peer discovery limit does not limit search eligibility. Other stock pairs remain available in the comparison tool.

Statements available through 2026-11-06. Industry snapshot: 2025-12-31 · 5,721 classified issuers.

Opening chat…

Preparing your conversation.